载脂蛋白CII p.Lys41Thr突变相关淀粉样变性
该研究从淀粉样物质谱队列中识别出5例肾脏载脂蛋白CII(AApoCII)p.Lys41Thr突变相关淀粉样变性患者。患者平均诊断年龄71.6岁,表现为肾病范围蛋白尿和肾功能下降,肾活检示肾小球系膜巨大结节状淀粉样沉积,质谱检测到APOC2突变蛋白。作者认为这是一种新的老年淀粉样变性类型,导致肾病范围蛋白尿和进行性慢性肾脏病。
要点
- 老年患者出现肾病范围蛋白尿和肾功能下降需警惕AApoCII淀粉样变性。
- 肾活检示肾小球系膜巨大结节状、PAS阴性、刚果红阳性淀粉样沉积。
- 质谱检测淀粉样沉积物中APOC2蛋白及p.Lys41Thr突变蛋白可辅助诊断。
核心结论
- AApoCII p.Lys41Thr淀粉样变性是老年个体中的一种新淀粉样变性类型,组织学表现为大量肾小球受累,导致肾病范围蛋白尿和进行性慢性肾脏病。
研究设计与样本
- 从淀粉样物质谱队列中识别5例肾脏AApoCII p.Lys41Thr淀粉样变性患者,分析临床特征、肾活检和质谱结果。
主要发现
- 患者平均诊断年龄71.6岁,表现为肾病范围蛋白尿,常伴肾功能下降。
- 所有肾活检标本示肾小球系膜巨大结节状、弱嗜酸性、PAS阴性、刚果红阳性淀粉样沉积,无间质、血管或髓质沉积。
- 免疫荧光Ig阴性,电镜示淀粉样纤维,质谱检测到大量APOC2蛋白及p.Lys41Thr突变蛋白。
- 1例DNA测序确认突变,所有患者沉积物中均检测到突变型和野生型APOC2。
- 分子动力学模拟显示该变异导致APOC2天然结构崩溃,使蛋白不稳定。
临床怎么用
- 对老年肾病范围蛋白尿伴肾功能下降患者,肾活检发现肾小球系膜结节状刚果红阳性沉积时,应考虑AApoCII淀粉样变性。
- 质谱检测淀粉样沉积物中的APOC2蛋白及突变蛋白有助于确诊。
局限性
- 样本量小(5例),仅1例经DNA测序确认突变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Apolipoprotein CII amyloidosis (AApoCII) is a rare form of amyloidosis. Here, we report a novel mutation associated with AApoCII amyloidosis in 5 patients and describe their clinical, renal biopsy, and mass spectrometry findings. METHODS: Five patients with renal AApoCII p.Lys41Thr amyloidosis were identified from our amyloid mass spectrometry cohort. Clinical features, kidney biopsy, and mass spectrometry findings were analyzed in this rare type of amyloidosis. RESULTS: The patients were older adults (mean age of 71.6 years at diagnosis), presented with nephrotic-range proteinuria, and often had declining renal function. All renal biopsy specimens showed massive mesangial nodules composed of weakly eosinophilic, periodic acid-Schiff negative, Congo red-positive amyloid deposits. There were no interstitial, vascular, or medullary deposits. In all cases, immunofluorescence studies were negative for Igs and electron microscopy showed amyloid fibrils. Proteomic analysis of Congo red-positive amyloid deposits detected large amounts of apolipoprotein CII (APOC2) protein. We also detected APOC2 p.Lys41Thr mutant protein in amyloid deposits of all patients. DNA sequencing in 1 patient confirmed the presence of the mutation. Both mutant and wild-type forms of APOC2 were detected in amyloid deposits of all patients. Molecular dynamic simulations showed the variant mediating a collapse of the native structure of APOC2, thereby destabilizing the protein. CONCLUSION: We propose that AApoCII p.Lys41Thr amyloidosis is a new form of amyloidosis seen in elderly individuals, histologically exhibiting massive glomerular involvement, leading to nephrotic-range proteinuria and progressive chronic kidney disease.
引用
- Sethi S, Dasari S, Plaisier E, et al. Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation. Kidney Int Rep. 2018. PMID: 30197986. doi:10.1016/j.ekir.2018.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。